Exploring lymphocyte subsets in COVID-19 patients: insights from a tertiary academic medical center with a high proportion of patients on immunosuppression
Lymphocyte subsets were not significantly different between SARS-CoV-2 negative and positive patients and between mild versus severe cases. Neither lymphocyte subsets nor prior immunosuppressive drug use were associated with COVID-19 severity.
Authors
- Katrijn Daenen (ORCID: https://orcid.org/0009-0003-5664-5393)
- P. Martin van Hagen (ORCID: https://orcid.org/0000-0003-0854-2368)
- Kirby Tong‐Minh (ORCID: https://orcid.org/0000-0002-8373-0011)
- Virgil A. S. H. Dalm (ORCID: https://orcid.org/0000-0001-5945-4435)
- Eric C. M. Van Gorp (ORCID: https://orcid.org/0000-0001-6415-6678)
- Willem A. Dik (ORCID: https://orcid.org/0000-0001-5235-3156)
- Jilske Huijben (ORCID: https://orcid.org/0000-0002-2892-5406)
- Diederik A M P J Gommers (ORCID: https://orcid.org/0000-0001-6808-7702)
- Samantha van Hooijdonk
- Henrik Endeman
Institutions
- Erasmus MC (NL)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-12-03
- DOI
- https://doi.org/10.3389/fimmu.2024.1436637
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00